Although testing for bullous pemphigoid (BP180/BP230) autoantibodies is recommended in the evaluation of lichenoid eruptions with possible pemphigoid overlap, this assay was not available in our institution at the time, and therefore could not be performed at that time. Here, COL17A1 is linked to autoimmune bullous skin disease.